ArticleInternational cancer conference journal2025
Tirabrutinib rechallenge achieved complete response for recurrent primary central nervous system lymphoma: illustrative case.
Daisuke Kawauchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.